Finally, we cannot exclude off-target effects of CFZ, such as PP2A activation and MCL1 inhibition [68,69], both of which are important targets in MPN [70,71], and may explain our findings in MF cells. This evidence concerns the gene MCL1 and myeloproliferative neoplasm.